Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LOVAZA
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- Immunonutrition for Diabetic Foot Ulcers
- Pro-Resolving Mediators in Acute Inflammation in Humans
- Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
- Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
- Bioavailability of EPA + DHA in a SMEDS Formulation
- QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
- QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL
- QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
- Derivatives of Omega-3 HUFA as Biomarkers of Traumatic Brain Injury
- An Open-Label Crossover Study to Compare the Relative Bioavailability, Efficacy and Safety of Epanova® and Lovaza® in Men and Women With a History of Pancreatitis
- Fish Oils and Adipose Inflammation Reduction
- The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)
- Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
- COGNUTRIN in Breast Cancer Survivors
- Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
- Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
- Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue
- Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
- Omega-3 Fatty Acids and Insulin Sensitivity
- Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
- A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
- Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals
- Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia
- Efficacy of TAK-085 in Participants With Hypertriglyceridemia
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
- Breast Cancer Risk Biomarkers in Postmenopausal Women
- Breast Cancer Risk Biomarkers in Premenopausal Women
- Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD
- Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation
- Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
- Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia
- Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
- The Effects of Lovaza® in Acute Myocardial Infarction
- Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
- Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
- Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
- Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Cardiac Antioxidant/Anti-inflammatory Profile Before Cardiac Surgery
- The Impact of Omega Three Fatty Acids on Vascular Function in HIV
- Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
- Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
- Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
- Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia
- The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
- Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
- Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
- Triglyceride Lowering Study
- Lovaza® and Microvascular Function in Type 2 Diabetes
- Fish Oil Study for High Triglyceride Levels in Children
- Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects
- A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
- Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Efficacy of Fish Oil in Lupus Patients
- Omega-3 for Peri- and Postmenopausal Depression
- A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
- The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
- Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
- Effects of Fish Oil on Post Ablation Arrhythmias
- The Effects of Omega-3 Fatty Acids on Aspirin Resistance
- Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids
- Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
- Women With Chest Pain and Normal Coronary Arteries Study
- Study of Fish Oil to Reduce ALT Levels in Adolescents
- Effects of Omacor and Aspirin on Platelet Function
- Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides
- Effects of Fish Oils on Inflammation and Insulin Resistance
- Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
- Lovaza Therapy of Peripheral Arterial Disease
- Lovaza's Effect on the Activation of Platelets
- Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
- An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
- Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
- Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
- Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
- Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects
- Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
Clinical trials list
click for details